BioLab Holdings, Inc. Announces Partnership with Real Collagen GmbH
Investment and Partnership will Allow Manufacturer to Create New Wound Care Products Using Fish Collagen PHOENIX, March 7, 2025 /PRNewswire/...
Day: March 7, 2025
OsteoCentric Technologies Accepts UH Haslam Sports Innovation Center’s First Investment to drive Orthopedic Sports Medicine Innovation
AUSTIN, Texas, March 7, 2025 /PRNewswire/ -- OsteoCentric Technologies, a company dedicated to redefining Orthopedic MIS bone preservation technology, is...
Waters Corporation to Present at the Leerink Partners Global Healthcare Conference
MILFORD, Mass., March 7, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D., Waters President and Chief...
IDBS Unveils IDBS Polar Control: Revolutionizing Process Management in BioPharmaceutical Development
WOKING, United Kingdom, March 7, 2025 /PRNewswire/ -- IDBS, a leading global provider of cloud software for BioPharma companies, is...
Pharmacy Automation Market worth US$10.00 billion by 2030 with 7.1% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., March 7, 2025 /PRNewswire/ -- The global Pharmacy Automation Market, valued at US$6.23 billion in 2023, is...
Hospital PMI® at 56%; February 2025 Hospital ISM® Report On Business®
TEMPE, Ariz., March 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in February for the 18th consecutive month...
Obesity Care Week 2025 Concludes with a Global Commitment to Care
TAMPA, Fla., March 7, 2025 /PRNewswire/ -- As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters...
RoC® Unveils RoC 35: the First Clinically Proven Skin Rejuvenating Protocol Tested in 35 French Clinics
Participants Report Looking Nearly 10 Years Younger After Only 90 Days NEW YORK, March 7, 2025 /PRNewswire/ -- RoC®, a...
Full Circles Therapeutics Secures U.S. Patent Allowance for Targeted Genome Modification Using Circular Single-Stranded DNA
CAMBRIDGE, Mass., March 7, 2025 /PRNewswire/ -- Full Circles Therapeutics, a leader in next-generation genome engineering, announces that the United...
American Public Education, Inc. Appoints Richard J. Statuto to its Board of Directors
A Former Health System CEO, Mr. Statuto Has Over 30 Years of Leadership Experience CHARLES TOWN, W.V., March 7, 2025...
Patient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology Studies
Insights into Hidradenitis Suppurativa from Target RWE Featured in Posters at AAD 2025 DURHAM, N.C., March 7, 2025 /PRNewswire/ --...
February Recap: 15 Top Health Press Releases
A roundup of the most newsworthy healthcare press releases from PR Newswire, including business strategies shaping the future of healthcare...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...
Revenue Cycle Optimizations Among Nextech Enhancements on Display at AAD 2025
Integrated Revenue Cycle Management (RCM) Enables Providers to Decrease Denied Claims and Increase ReimbursementTAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE)...
Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent
Hamilton, March 07, 2025 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (OTCQB:CYTOF) today announced that the U.S. Patent and Trademark Office...
Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update
LONDON AND PHILADELPHIA, March 07, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, ‘the Company’), a life sciences company developing...
PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
First-ever HPV16-positive head and neck cancer Phase 3 clinical trialPRINCETON, N.J., March 07, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation...
ICU Medical to Participate at the KeyBanc Healthcare Forum
SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale...
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security SectorsWEXFORD, Pa., March 07, 2025 (GLOBE NEWSWIRE)...